Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Eaton

Showing results (31-40 of 148) with videos related to

Pageof 15
Sort By:
Diabetes|November 1, 1975
Modulation of fatty acid metabolism by glucagon in man. III. Role of pharmacologic limitation of FFA availabilityD S Schade, R P Eaton
Diabetes|May 1, 1975
Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabeticsD S Schade, R P Eaton
Diabetes|January 1, 1982
Bactericidal properties of commercial U.S.P. formulated insulinD S Schade, R P Eaton
JAMA|November 30, 1979
Prevention of diabetic ketoacidosisD S Schade, R P Eaton
Diabetologia|December 1, 1975
The contribution of endogenous insulin secretion to the ketogenic response to glucagon in manD S Schade, R P Eaton
The New England Journal of Medicine|April 25, 1985
Insulin delivery: how, when, and whereD S Schade, R P Eaton
Diabetes|January 1, 1979
The regulation of plasma ketone body concentration by counter-regulatory hormones in man. III. Effects of norepinephrine in normal manD S Schade, R P Eaton
The New England Journal of Medicine|November 9, 1995
Images in clinical medicine. Osmotic myelinolysisB L Hart, R P Eaton
Special Topics in Endocrinology and Metabolism|January 1, 1982
Metabolic and clinical significance of ketosisD S Schade, R P Eaton
Diabetes Care|March 1, 1980
The peritoneum--a potential insulin delivery route for a mechanical pancreasD S Schade, R P Eaton
Pageof 15

Showing results (31-40 of 148) with videos related to

Sort By:
Pageof 15
Diabetes|November 1, 1975
Modulation of fatty acid metabolism by glucagon in man. III. Role of pharmacologic limitation of FFA availabilityD S Schade, R P Eaton
Diabetes|May 1, 1975
Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabeticsD S Schade, R P Eaton
Diabetes|January 1, 1982
Bactericidal properties of commercial U.S.P. formulated insulinD S Schade, R P Eaton
JAMA|November 30, 1979
Prevention of diabetic ketoacidosisD S Schade, R P Eaton
Diabetologia|December 1, 1975
The contribution of endogenous insulin secretion to the ketogenic response to glucagon in manD S Schade, R P Eaton
The New England Journal of Medicine|April 25, 1985
Insulin delivery: how, when, and whereD S Schade, R P Eaton
Diabetes|January 1, 1979
The regulation of plasma ketone body concentration by counter-regulatory hormones in man. III. Effects of norepinephrine in normal manD S Schade, R P Eaton
The New England Journal of Medicine|November 9, 1995
Images in clinical medicine. Osmotic myelinolysisB L Hart, R P Eaton
Special Topics in Endocrinology and Metabolism|January 1, 1982
Metabolic and clinical significance of ketosisD S Schade, R P Eaton
Diabetes Care|March 1, 1980
The peritoneum--a potential insulin delivery route for a mechanical pancreasD S Schade, R P Eaton
Pageof 15